Viatris Operating Income 2010-2024 | VTRS

Viatris annual/quarterly operating income history and growth rate from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Viatris operating income for the quarter ending September 30, 2024 was $0.226B, a 49.99% decline year-over-year.
  • Viatris operating income for the twelve months ending September 30, 2024 was $-0.265B, a 125.96% decline year-over-year.
  • Viatris annual operating income for 2023 was $0.766B, a 52.55% decline from 2022.
  • Viatris annual operating income for 2022 was $1.615B, a 4849.98% decline from 2021.
  • Viatris annual operating income for 2021 was $-0.034B, a 83.87% decline from 2020.
Viatris Annual Operating Income
(Millions of US $)
2023 $766
2022 $1,615
2021 $-34
2020 $-211
2019 $716
2018 $906
2017 $1,437
2016 $699
2015 $1,461
2014 $1,353
2013 $1,136
2012 $1,109
2011 $1,005
2010 $722
2009 $523
Viatris Quarterly Operating Income
(Millions of US $)
2024-09-30 $226
2024-06-30 $-240
2024-03-31 $204
2023-12-31 $-455
2023-09-30 $452
2023-06-30 $369
2023-03-31 $400
2022-12-31 $-201
2022-09-30 $560
2022-06-30 $549
2022-03-31 $707
2021-12-31 $-78
2021-09-30 $358
2021-06-30 $-48
2021-03-31 $-266
2020-12-31 $-881
2020-09-30 $351
2020-06-30 $134
2020-03-31 $185
2019-12-31 $272
2019-09-30 $324
2019-06-30 $96
2019-03-31 $24
2018-12-31 $233
2018-09-30 $338
2018-06-30 $179
2018-03-31 $156
2017-12-31 $419
2017-09-30 $317
2017-06-30 $474
2017-03-31 $228
2016-12-31 $313
2016-09-30 $-131
2016-06-30 $411
2016-03-31 $106
2015-12-31 $424
2015-09-30 $601
2015-06-30 $277
2015-03-31 $159
2014-12-31 $393
2014-09-30 $495
2014-06-30 $226
2014-03-31 $239
2013-12-31 $273
2013-09-30 $340
2013-06-30 $309
2013-03-31 $214
2012-12-31 $263
2012-09-30 $335
2012-06-30 $261
2012-03-31 $251
2011-12-31 $247
2011-09-30 $266
2011-06-30 $280
2011-03-31 $212
2010-12-31 $94
2010-09-30 $234
2010-06-30 $195
2010-03-31 $199
2009-12-31 $60
2009-09-30 $61
2009-06-30 $175
2009-03-31 $227
Sector Industry Market Cap Revenue
Medical Medical Services $15.576B $15.427B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Avantor (AVTR) United States $13.422B 20.12
Revvity (RVTY) United States $13.376B 23.24
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
Charles River Laboratories (CRL) United States $9.516B 18.39
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00